In stage III–IVA disease, ICI monotherapy significantly improved OS compared with chemotherapy (HR, 0.28; P=0.038), with a favorable trend observed for ICI–chemo (HR, 0.32).
← all excerpts
Optimizing Postoperative Management in Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Gastroesophageal Junction Adenocarcinoma: A Multicenter Retrospective Study.
1
—
—